IHDPC, Rwanda Biomedical Center, Kigali, Kigali City, Rwanda
School of Population and Public Health, The University of British Columbia, Vancouver, British Columbia, Canada.
BMJ Open. 2020 Jul 12;10(7):e036711. doi: 10.1136/bmjopen-2019-036711.
This study describes the burden of the hepatitis B, C and HIV co-infections and assesses associated risk factors.
This analysis used data from a viral hepatitis screening campaign conducted in six districts in Rwanda from April to May 2019. Ten health centres per district were selected according to population size and distance.
The campaign collected information from 156 499 participants (51 496 males and 104 953 females) on sociodemographic, clinical and behavioural characteristics. People who were not Rwandan by nationality or under 15 years old were excluded.
The outcomes of interest included chronic hepatitis C virus (HCV) infection, chronic hepatitis B virus (HBV) infection, HIV infection, co-infection HIV/HBV, co-infection HIV/HCV, co-infection HBV/HCV and co-infection HCV/HBV/HIV. Multivariable logistic regressions were used to assess factors associated with HBV, HCV and HIV, mono and co-infections.
Of 156 499 individuals screened, 3465 (2.2%) were hepatitis B surface antigen positive and 83% (2872/3465) of them had detectable HBV desoxy-nucleic acid (HBV DNA). A total of 4382 (2.8%) individuals were positive for antibody-HCV (anti-HCV) and 3163 (72.2%) had detectable HCV ribo-nucleic acid (RNA). Overall, 36 (0.02%) had HBV/HCV co-infection, 153 (0.1%) HBV/HIV co-infection, 238 (0.15%) HCV/HIV co-infection and 3 (0.002%) had triple infection. Scarification or receiving an operation from traditional healer was associated with all infections. Healthcare risk factors-history of surgery or transfusion-were associated with higher likelihood of HIV infection with OR 1.42 (95% CI 1.21 to 1.66) and OR 1.48 (1.29 to 1.70), respectively, while history of physical traumatic assault was associated with a higher likelihood of HIV and HBV/HIV co-infections with OR 1.69 (95% CI 1.51 to 1.88) and OR 1.82 (1.08 to 3.05), respectively.
Overall, mono-infections were common and there were differences in significant risk factors associated with various infections. These findings highlight the magnitude of co-infections and differences in underlying risk factors that are important for designing prevention and care programmes.
本研究描述了乙型肝炎、丙型肝炎和 HIV 合并感染的负担,并评估了相关的危险因素。
本分析使用了 2019 年 4 月至 5 月在卢旺达六个地区进行的病毒性肝炎筛查活动的数据。根据人口规模和距离,每个地区选择了 10 个卫生中心。
该活动收集了来自 156499 名参与者(51496 名男性和 104953 名女性)的社会人口统计学、临床和行为特征信息。国籍不是卢旺达或年龄在 15 岁以下的人被排除在外。
感兴趣的结果包括慢性丙型肝炎病毒(HCV)感染、慢性乙型肝炎病毒(HBV)感染、HIV 感染、HBV/HIV 合并感染、HBV/HCV 合并感染、HBV/HCV/HIV 合并感染和 HCV/HBV/HIV 合并感染。多变量逻辑回归用于评估与 HBV、HCV 和 HIV、单感染和合并感染相关的因素。
在筛查的 156499 人中,3465 人(2.2%)乙肝表面抗原阳性,其中 83%(2872/3465)的人有可检测到的乙肝脱氧核酸(HBV DNA)。共有 4382 人(2.8%)抗体-HCV(抗-HCV)阳性,其中 3163 人(72.2%)有可检测到的 HCV 核糖核酸(RNA)。总体而言,36 人(0.02%)有 HBV/HCV 合并感染,153 人(0.1%)有 HBV/HIV 合并感染,238 人(0.15%)有 HCV/HIV 合并感染,3 人(0.002%)有三重感染。划痕或接受传统治疗师的手术与所有感染有关。医疗保健风险因素-手术或输血史-与 HIV 感染的可能性更高相关,OR 1.42(95%CI 1.21-1.66)和 OR 1.48(1.29-1.70),而身体创伤性攻击史与 HIV 和 HBV/HIV 合并感染的可能性更高相关,OR 1.69(95%CI 1.51-1.88)和 OR 1.82(1.08-3.05)。
总体而言,单感染很常见,与各种感染相关的显著危险因素存在差异。这些发现突出了合并感染的程度和潜在风险因素的差异,这对于设计预防和护理计划非常重要。